| Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma (NCT01478360) | Novartis Pharmaceuticals | 2012-03-01 |
| Effects of Whole Sprouts on Airway Allergic Inflammation (NCT01522703) | Johns Hopkins University | 2012-03-01 |
| Exhaled Nitric Oxide in Asthma Management (NCT02140684) | Research in Real-Life Ltd | 2012-03-01 |
| WheezoMeter® Correlation Study (NCT01556958) | iSonea | 2012-03-01 |
| Study of JNJ-39758979 in Symptomatic Adult Patients With Uncontrolled Asthma (NCT01493882) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2012-03-01 |
| Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis (NCT01550471) | West Penn Allegheny Health System | 2012-03-01 |
| Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212) (NCT01566149) | Organon and Co | 2012-03-01 |
| A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE) (NCT01545440) | Genentech, Inc. | 2012-03-01 |
| Risk Factors for Early Remodelling in Severe Asthma in Children (NCT02806466) | University Hospital, Bordeaux | 2012-03-01 |
| Collaborative Healthcare Professionals Approach in Monitoring of Patient Centered Outcomes Through Pathways (NCT01561885) | Majed Aljeraisy | 2012-03-01 |
| Exploring a Cessation Intervention for Smokers (NCT01728038) | Children's Hospital Medical Center, Cincinnati | 2012-03-01 |
| A Single Dose Pharmacokinetics (PK) Study of GSK2434735 in Healthy Male Volunteers (NCT01563042) | GlaxoSmithKline | 2012-02-13 |
| Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma (NCT01501942) | AIM Therapeutics Inc. | 2012-02-01 |
| Prospective Study of the Feedback From an Adherence Monitor on Asthma Control (NCT01529697) | Beaumont Hospital | 2012-02-01 |
| Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients (NCT01521455) | Hanmi Pharmaceutical Company Limited | 2012-02-01 |
| Determining the Optimal Adenosine Provocation Test (NCT01610921) | University Medical Center Groningen | 2012-02-01 |
| Single-Dose Clinical Pharmacology Study in Asthmatic Adolescent and Adult Patients (NCT01803087) | Chiesi Farmaceutici S.p.A. | 2012-02-01 |
| Effects of Leukotriene Modulator Montelukast on Cough Variant Asthma (NCT01404013) | The First Affiliated Hospital of Guangzhou Medical University | 2012-02-01 |
| Efficacy of Educational Intervention for Parents of Children With Asthma (NCT01979224) | Universidad Autonoma de San Luis Potosí | 2012-02-01 |
| A Study to Establish the Efficacy of QBX258 in Patients With Moderate to Severe Asthma (NCT01479595) | Novartis Pharmaceuticals | 2012-02-01 |
| Bioavailability Study of SYN006, Pulmicort pMDI and Meptin Air in Healthy Adult. (NCT02165046) | Intech Biopharm Ltd. | 2012-02-01 |
| Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth (NCT01520688) | West Penn Allegheny Health System | 2012-02-01 |
| Safety and Efficacy of QAW039 in Sputum Eosinophilia and Persistent Asthma (NCT01545726) | Novartis Pharmaceuticals | 2012-02-01 |
| A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223) (NCT01502371) | Organon and Co | 2012-01-25 |
| A Single Centre Study in Healthy Volunteers to Optimise the Rotacap Formulation and ROTAHALER Device for Delivery of Fluticasone Propionate/Salmeterol (NCT01540708) | GlaxoSmithKline | 2012-01-16 |
| A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241) (NCT01471340) | Organon and Co | 2012-01-09 |
| Role of microRNAs in T Cell-Driven Inflammation in Asthma (NCT01484691) | University of California, San Francisco | 2012-01-01 |
| Study of Dose-response to Bronchodilator and Dose-finding in Child 2.5 to 6 Years - Study Golden (NCT01470755) | Assistance Publique - Hôpitaux de Paris | 2012-01-01 |
| Imaging Lung Function Using Oxygen Enhanced MRI (NCT01731015) | Hal C Charles | 2012-01-01 |
| Pilot Study of Magnesium Infusions in Pediatric Asthma (NCT01522040) | University of Louisville | 2012-01-01 |
| Effect of a Component of Fish Oil on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma (NCT01504646) | Indiana University | 2012-01-01 |
| Effect of Intranasal Corticosteroids on Pulmonary Symptoms in Asthmatics With Nasal Congestion (NCT01562093) | St. Olavs Hospital | 2012-01-01 |
| Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry (NCT01498653) | GlaxoSmithKline | 2012-01-01 |
| A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids (NCT01479621) | Teva Branded Pharmaceutical Products R&D, Inc. | 2012-01-01 |
| A Study Comparative of Formoterol/Fluticasone Foraseq® and Fluticasone in Asthma Patients (NCT01202084) | Eurofarma Laboratorios S.A. | 2012-01-01 |
| Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation (NCT01515995) | University of Texas Southwestern Medical Center | 2012-01-01 |
| A Study of a New Asthma Medicine in Asthmatics Whose Asthma Worsens With Exercise (NCT01435902) | GlaxoSmithKline | 2012-01-01 |
| Relief of Acute Bronchoconstriction/Asthma Using the Non-Invasive AlphaCore Device (NCT01532817) | ElectroCore INC | 2012-01-01 |
| Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma (NCT01589198) | National Jewish Health | 2012-01-01 |
| Mepolizumab Treatment for Rhinovirus-induced Asthma Exacerbations (NCT01520051) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2012-01-01 |
| Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry. (NCT01498679) | GlaxoSmithKline | 2012-01-01 |
| Bioequivalence Study to Compare Fluticasone Furoate (FF) 1-strip Inhaler With FF 2-strip Inhaler and With FF/Vilanterol Combination (NCT01485445) | GlaxoSmithKline | 2011-12-21 |
| Vitamin D for Sickle-cell Respiratory Complications (NCT01443728) | Gary M Brittenham, MD | 2011-12-13 |
| AMG 761 in Adults With Asthma (NCT01514981) | Amgen | 2011-12-01 |
| Bronchodilator Response in 4-12 Years Chinese Controller Naive Asthmatic Children (NCT01500525) | Capital Institute of Pediatrics, China | 2011-12-01 |
| The Clinical Effect of Monodisperse Fluticasone Propionate in Asthma (NCT01662778) | Imperial College London | 2011-12-01 |
| Quality of Life in Asthmatic Children at School Age (NCT01475916) | University Hospital, Clermont-Ferrand | 2011-12-01 |
| Multi-Component Technology Intervention for Minority Emerging Adults With Asthma (NCT01714141) | Wayne State University | 2011-12-01 |
| Bronchodilator Effect of CHF1535 pMDI Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmatic Children (NCT01584492) | Chiesi Farmaceutici S.p.A. | 2011-12-01 |
| A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents (NCT01444430) | AstraZeneca | 2011-12-01 |
| Probiotics and Allergic Diseases (NCT01635738) | GenMont Biotech Incorporation | 2011-12-01 |
| SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma. (NCT01475721) | GlaxoSmithKline | 2011-11-18 |
| 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old (NCT01462344) | GlaxoSmithKline | 2011-11-17 |
| Safety, Tolerability, and Pharmacokinetics of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects (NCT01470911) | Sterna Biologicals GmbH & Co. KG | 2011-11-01 |
| Safety and Efficacy of YHD001 in Asthma (NCT01424124) | Yuhan Corporation | 2011-11-01 |
| Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Short Acting Beta-2 Agonist (SABA) Therapy Alone (NCT01458886) | Boehringer Ingelheim | 2011-11-01 |
| Is a Diet Necessary When Corticosteroid Treatment is Prescribed? (NCT01420133) | Assistance Publique - Hôpitaux de Paris | 2011-11-01 |
| Small Airways Involvement in Smoker Asthmatic Patients: a Pilot Study (NCT01620099) | Università degli Studi di Ferrara | 2011-11-01 |
| Lung Function Changes of Induced Asthma Children Treated With Inhaled MgSO4 (NCT01856959) | Chongqing Medical University | 2011-11-01 |
| Qvar Therapy in Smoking Asthmatics (NCT01729351) | Research in Real-Life Ltd | 2011-11-01 |
| A Study to Evaluate the Effects of Indacaterol Maleate as a New Formulation in the Concept 1 Device (NCT01484197) | Novartis Pharmaceuticals | 2011-11-01 |
| Study for Asthma Education in Primary Schools (NCT01607749) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2011-11-01 |
| Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory Symptoms (NCT01518322) | Aerocrine AB | 2011-11-01 |
| Safety Study in Adolescent and Adult Patients With Asthma (NCT01476904) | Amphastar Pharmaceuticals, Inc. | 2011-11-01 |
| Lung Function of Asthmatic Children by Nebulized MgSO4 (NCT01799109) | Chongqing Medical University | 2011-11-01 |
| Strategies to Improve Asthma and Treatment of Asthma in Canadians (NCT01525381) | Ottawa Hospital Research Institute | 2011-11-01 |
| Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroids (NCT01458912) | Boehringer Ingelheim | 2011-11-01 |
| Mannitol (Aridol) and Methacholine (Provocholine) Responsiveness (NCT01642745) | University of Saskatchewan | 2011-11-01 |
| A Single Blind Study to Evaluate the Safety, Tolerability and Explore the Efficacy of 8.0 mg ASM8 Inhaled Daily for 14 Days in Severe Asthma (NCT01380236) | Syntara | 2011-11-01 |
| Exercise Training in Asthma Children (NCT01438294) | Hospital Sirio-Libanes | 2011-11-01 |
| New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day (NCT01360021) | AstraZeneca | 2011-11-01 |
| Double-blind, Multiple Dose Study of Tezepelumab (AMG 157) in Adults With Mild Atopic Asthma (NCT01405963) | Amgen | 2011-10-31 |
| Efficacy of a Minimal Intervention Educational Program in the Asthma Control and Exacerbations Prevention (NCT01282359) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2011-10-01 |
| Olodaterol Bridging Study in Asthma (NCT01428622) | Boehringer Ingelheim | 2011-10-01 |
| Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma (NCT01472757) | Vectura Limited | 2011-10-01 |
| E-support for Healthcare Processes - ASTHMA (NCT01461642) | The University Clinic of Pulmonary and Allergic Diseases Golnik | 2011-10-01 |
| Identification of Plasma miRNAs as Potential Biomarkers in Asthma Exacerbation (NCT01631760) | University of South Florida | 2011-10-01 |
| Bacille Calmette-Guérin (BCG) Vaccine and Atopy (NCT01420705) | Bandim Health Project | 2011-10-01 |
| Effect of Home Health Case Management on Asthma Morbidity (NCT01451944) | University of Louisville | 2011-10-01 |
| Observational Study to Evaluate the Correctness of the Use of Inhaler Device in Patients With Asthma or Chronic Obstruct (NCT01426893) | AstraZeneca | 2011-10-01 |
| Electrophilic Fatty Acid Derivatives in Asthma (NCT01733485) | Sally E. Wenzel MD | 2011-10-01 |
| Asthma and Quantifying Delivery Of Radio Labeled Aerosol (NCT01823926) | Universidade Federal de Pernambuco | 2011-10-01 |
| Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD Study (NCT01453023) | GlaxoSmithKline | 2011-10-01 |
| Evaluation of Efficacy and Safety of E004 in Children With Asthma (NCT01460511) | Amphastar Pharmaceuticals, Inc. | 2011-10-01 |
| Neural Mechanisms in Asthma (NCT01155843) | University of Wisconsin, Madison | 2011-10-01 |
| A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma (NCT01436890) | Glenmark Pharmaceuticals Ltd. India | 2011-10-01 |
| Assessing Decision Maker Tools for Asthma: the Asthma APGAR (NCT01446315) | Olmsted Medical Center | 2011-10-01 |
| Childhood Asthma Reduction Study (NCT01468805) | National Institute of Environmental Health Sciences (NIEHS) | 2011-09-04 |
| Efficacy and Safety of Increasing Doses of Inhaled Albuterol in Children With Acute Wheezing Episodes (NCT01323010) | University of Sao Paulo | 2011-09-01 |
| Stimulation of the Cervical Sympathetic Ganglion for Treatment of Asthma (NCT01724307) | Jonathan Parsons | 2011-09-01 |
| Efficacy Study of the Product "CHF 1535" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children (NCT01475032) | Chiesi Farmaceutici S.p.A. | 2011-09-01 |
| Development of Small Airway Disease Questionnaire (NCT01360294) | University Medical Center Groningen | 2011-09-01 |
| Reducing Asthma Morbidity In High Risk Minority Preschool Children (NCT01519453) | Johns Hopkins University | 2011-09-01 |
| Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents (NCT01431950) | GlaxoSmithKline | 2011-09-01 |
| MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects (NCT01833390) | Xemed LLC | 2011-09-01 |
| Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma (NCT01436071) | GlaxoSmithKline | 2011-09-01 |
| DO IT Trial: Vitamin D Outcomes and Interventions In Toddlers (NCT01419262) | The Hospital for Sick Children | 2011-09-01 |
| AZithromycin Against pLacebo in Exacerbations of Asthma (NCT01444469) | Imperial College London | 2011-09-01 |
| Mannitol Challenge Test in Adult Asthma Patients With Fixed Dose Combinations (NCT01449123) | Mundipharma AB | 2011-09-01 |
| Documentation of Continuous Wheeze and Cough Dynamics in Pediatric ER SOB Patients (NCT01414322) | KarmelSonix Ltd. | 2011-09-01 |